Values of Donor Serum Lipids and Calcium in Predicting Graft Function after Kidney Transplantation: A Retrospective Study

Abstract

Objective

Delayed graft function (DGF) and early graft loss of renal grafts are determined by the quality of the kidneys from the deceased donor. As “non-traditional” risk factors, serum biomarkers of donors, such as lipids and electrolytes, have drawn increasing attention due to their effects on the postoperative outcomes of renal grafts. This study aimed to examine the value of these serum biomarkers for prediction of renal graft function.

Methods

The present study consecutively collected 306 patients who underwent their first single kidney transplantation (KT) from adult deceased donors in our center from January 1, 2018 to December 31, 2019. The correlation between postoperative outcomes [DGF and abnormal serum creatinine (SCr) after 6 and 12 months] and risk factors of donors, including gender, age, body mass index (BMI), past histories, serum lipid biomarkers [cholesterol, triglyceride, high-density lipoprotein (HDL) and low-density lipoprotein (DL)], and serum electrolytes (calcium and sodium) were analyzed and evaluated.

Results

(1) Donor age and pre-existing hypertension were significantly correlated with the incidence rate of DGF and high SCr level (≥2 mg/dL) at 6 and 12 months after KT (P<0.05); (2) The donor’s BMI was significantly correlated with the incidence rate of DGF after KT (P<0.05); (3) For serum lipids, merely the low level of serum HDL of the donor was correlated with the reduced incidence rate of high SCr level at 12 months after KT [P<0.05, OR (95% CI): 0.425 (0.202–0.97)]; (4) The serum calcium of the donor was associated with the reduced incidence rate of high SCr level at 6 and 12 months after KT [P<0.05, OR (95% CI): 0.184 (0.045–0.747) and P<0.05, OR (95% CI): 0.114 (0.014–0.948), respectively].

Conclusion

The serum HDL and calcium of the donor may serve as predictive factors for the postoperative outcomes of renal grafts after KT, in addition to the donor’s age, BMI and pre-existing hypertension.

Keywords

delayed graft function / serum creatinine / serum high-density lipoprotein / serum calcium / kidney transplantation

References

[1] WolfeRA, AshbyVB, MilfordEL, et al.. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med, 1999, 341(23): 1725-1730

[2] DewMA, SwitzerGE, GoycooleaJM, et al.. Does transplantation produce quality of life benefits? A quantitative analysis of the literature. Transplantation, 1997, 64(9): 1261-1273

[3] ReesePP, HallIE, WengFL, et al.. Associations between Deceased-Donor Urine Injury Biomarkers and Kidney Transplant Outcomes. J Am Soc Nephrol, 2016, 27(5): 1534-1543

[4] MoresoF, SerónD, Gil-VernetS, et al.. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant, 1999, 14(4): 930-935

[5] QuirogaI, McShaneP, KooDD, et al.. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant, 2006, 21(6): 1689-1696

[6] MooreJ, RamakrishnaS, TanK, et al.. Identification of the optimal donor quality scoring system and measure of early renal function in kidney transplantation. Transplantation, 2009, 87(4): 578-586

[7] ScholdJD, KaplanB, BaligaRS, et al.. The broad spectrum of quality in deceased donor kidneys. Am J Transplant, 2005, 5(4): 757-765 Pt 1

[8] ScianMJ, MalufDG, ArcherKJ, et al.. Identification of biomarkers to assess organ quality and predict posttransplantation outcomes. Transplantation, 2012, 94(8): 851-858

[9] A Guide to Calculating and Interpreting the Kidney Donor Profile Index (KDPI). Health Resources and Services Administration. Updated May 15, 2019. Organ Procurement and Transplantation Network. (https://optn.transplant.hrsa.gov/)

[10] ShutoE, TaketaniY, TanakaR, et al.. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol, 2009, 20(7): 1504-1512

[11] StevensKK, MorganIR, PatelRK, et al.. Serum phosphate and outcome at one year after deceased donor renal transplantation. Clin Transplant, 2011, 25(2): E199-E204

[12] MahmoudAA, El-ShaarawyAM, MansourMA, et al.. Perioperative Calcium, Magnesium, and Phosphorus Levels in Live Donors For Liver Transplant. Exp Clin Transplant, 2015, 13(6): 550-555

[13] IssaN, StephanyB, FaticaR, et al.. Donor factors influencing graft outcomes in live donor kidney transplantation. Transplantation, 2007, 83(5): 593-599

[14] YoonYE, ChoiKH, KimKH, et al.. Clinical assessment of lipid profiles in live kidney donors. Transplant Proc, 2015, 47(3): 584-587

[15] RaoPS, SchaubelDE, GuidingerMK, et al.. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation, 2009, 88(2): 231-236

[16] ChevarriaJ, SextonDJ, MurraySL, et al.. Calcium and phosphate levels after kidney transplantation and long-term patient and allograft survival. Clin Kidney J, 2021, 14(4): 1106-1113

[17] SchaeffnerES, FödingerM, KramarR, et al.. Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int, 2007, 20(3): 247-255

[18] BoomH, MallatMJ, de FijterJW, et al.. Calcium levels as a risk factor for delayed graft function. Transplantation, 2004, 77(6): 868-873

[19] HasanzamaniB, KarimiN, SabbaghMG, et al.. The Relationship Between Pre-Transplant Serum Phosphorus Before Kidney Transplantation with Early Graft Dysfunction. Iran J Kidney Dis, 2021, 1(2): 148-154

[20] K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis, 2003,42(4 Suppl 3):S1-S201

[21] McCannL. Calcium in chronic kidney disease: recommended intake and serum targets. Adv Chronic Kidney Dis, 2007, 14(1): 75-78

[22] Qunibi WY. Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end-stage renal disease (ESRD). Kidney Int Suppl, 2005,(95): S43–S50

[23] SchaeffnerES, FödingerM, KramarR, et al.. Prognostic associations between lipid markers and outcomes in kidney transplant recipients. Am J Kidney Dis, 2006, 47(3): 509-517

[24] Di AngelantonioE, SarwarN, PerryP, et al.. Major lipids, apolipoproteins, and risk of vascular disease. JAMA, 2009, 302(18): 1993-2000

[25] ZhongJ, YangH, KonV. Kidney as modulator and target of “good/bad” HDL. Pediatr Nephrol, 2019, 34(10): 1683-1695

[26] ZhouY, YangHY, ZhangHL, et al.. High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery. BMC Nephrol, 2020, 21(1): 149

[27] AnnemaW, von EckardsteinA. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ J, 2013, 77(10): 2432-2448

[28] AsztalosBF, CollinsD, CupplesLA, et al.. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol, 2005, 25(10): 2185-2191